Matthew Jackson is a versatile pharmaceutical leader with extensive experience in drug product development, having worked at AbbVie and Alkermes. Currently serving as a Principal Research Scientist II at AbbVie, they lead the US Pharmacokinetic team within the QTAS department, overseeing preclinical studies. Prior to this role, Matthew held positions at AbbVie and Celgene, demonstrating expertise from preclinical to commercial stages of pharmaceutical science. Matthew earned both a Bachelor of Science and a Doctor of Philosophy in Pharmaceutics from Purdue University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices